Release Date: 22/05/17 16:39 Summary: NON-RENOUNCEABLE ENTITLEMENT OFFER Price Sensitive: Yes Download Document 513.95KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status